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Abstract
Background: This study was carried out to highlight the reversible physiological changes in pregnancy with 
demonstrable hypercoagulability though counterbalanced by increased fibrinolytic activity. An imbalance in these 
physiological changes may result in thrombotic disorder or haemorrhage.
C
Method: Coagulation tests ((PT, PTT , fibrinogen level and factor VIII ) were performed on 150 healthy pregnant k
Nigerian women, compared with 50 non-pregnant healthy Nigerian women using standard methods.
Results: The outcome of coagulation screening tests consistently showed shortening of PT and PTTk in each 
C
trimester of pregnancy while the factor VIII  and fibrinogen level increased with each trimester.
Conclusion: It is therefore suggested that serial coagulation studies should be performed on all pregnant women, 
particularly where there is an additional predisposing factor to DVT such as inherited thrombophilias and any of the 
hypercoagulable states. Where global tests of coagulation and specific factors assay suggest moderately severe 
hypercoagulable state, prophylactic anticoagulation should be considered.
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 Introduction
Normal haemostasis is a complicated phenomenon 
during which the vascular endothelium, platelets, 
procoagulant factors, coagulation inhibitors and the 
fibrinolytic system interplay to keep a balance between 
thrombosis and haemorrhage. Normal pregnancy is 
accompanied by significant alteration in all aspects of 
Virchows triad: venous stasis, endothelial damage, 
enhanced coagulation, ultimately shifting the 
 1
equilibrium towards a prothrombotic state . Placental 
separation is an acute and severe challenge to 
 2haemostasis  hence these changes serve to ensure 
haemostasis at the placental bed and prevent severe 
bleeding during delivery and the puerperium. Ongoing 
intra and extra vascular fibrin formation in the utero-
placental vasculature is a major contributor to the 
haemostatic changes in pregnancy.
However major changes in coagulation and 
fibrinolytic system may result in both thromboembolic 
 3disorders and haemostatic failure . Pregnancy is 
4 associated with a hypercoagulable state, resulting in 
increased thrombotic risk during the antenatal period, 
(5}
labour, and in postnatal period . The risk is escalated 
in individuals with inherited thrombophilia like protein 
C and S deficiency, factor V leiden, hereditary ATIII 
deficiency, factor II G20210A deficiency. Acquired 
causes of thrombophilia/systemic diseases like 
antiphospholipid syndrome, nephrotic syndrome, 
Paroxysmal Nocturnal Haemoglobinuria (PNH), 
cancer, sepsis, inflammatory bowel disease, 
myeloproliferative disorders etc; heighten the risk of 
6thrombosis . Efficient uteroplacental circulation 
determines the successful outcome of pregnancy. A 
bleeding tendency would occur in pregnancy when 
there is a deficiency of clotting factors, inhibition of the 
clotting process, or excessive activity of fibrinolytic 
 7system .
Studies indicating the coagulation profile at each 
trimester are lacking in this environment. Therefore, 
this study was carried out to find out the baseline value 
of PT, PTT  and to determine correlation between k
Cfibrinogen, factor VIII  and gestational age. This study 
also aimed at providing standard values for PT, PTT , k
CFibrinogen and factor VIII  in Nigerian pregnant 
women. 
Materials and Methods.
One hundred and fifty healthy pregnant women 
attending the antenatal clinic of university College 
Hospital, Ibadan; aged 19 to 35 years, without a history 
of coagulation disorder and who were not on any drug 
that could affect coagulation within the past six months, 
were recruited into this study. Fifty (50) non-pregnant 
women, age and gestational-age matched were selected 
as controls.
Samples for coagulation tests were taken as follows: 
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4.5ml of blood was obtained from each of the study and 
control subjects and added to 0.5ml of 3.2% trisodium 
citrate. The citrated samples were centrifuged for 
15mins at 2,000rpm to obtain platelet poor plasma. The 
plasma from each sample was carefully aspirated using 
0plastic Pasteur pipette and stored at 20 C prior to 
analysis.
Prothrombin Time was performed using the standard 
 8.
method of Quick A.J 1942  Partial Prothrombin Time 
with Kaolin (PTT ) was performed according to k
9Macpherson and Hardisty 1961 ; Procter and Rapaport 
 101961 .  Fibrinogen estimation was done according to 
11the method of Clauss (1957) , Ellis and Stransky 
12 C(1961) . The one-stage assay for factor VIII  was done 
 13using the method of Pitney (1956) . The principle is 
based on the partial thromboplastin time with kaolin 
(PTT ). It consists of comparing the ability of dilution k
of the patients plasma and of a standard plasma to 
C
correct the PTT of a plasma known to lack factor VIII  k 
but containing all other factors required for normal 
coagulation.
Fibrinogen estimation was done according to the 
method of Clauss as follows:- 0.2ml of 1 in 10 dilution 
of the citrated sample was placed in khan tubes in a 
0water bath at  37 C; 0.2ml of thrombin solution was 
added and a stopwatch was started simultaneously. The 
tube was tilted at intervals and the time for fibrin 
formation was noted. The tests were done in duplicate 
and the mean time was taken. The fibrinogen 
concentration was determined for each sample from the 
standard curve. 
Results
The mean PT, and PTT  were shorter than that of the k
controls in all trimesters and shortest in the third 
trimester. 
Table 1 shows the mean PT, PTT , Fibrinogen, and k
Cfactor VIII  for the control subjects and for each 
trimester of pregnancy. Fibrinogen levels were higher 
than in the control values but highest in the third 
Ctrimester. Factor VIII  level in each of the trimester was 
higher than that of controls but highest in the second 
trimester than the first and third trimester.
Table 2 shows the intra-group comparison of means of 
fibrinogen value for control versus the study subjects in 
the first trimester, first versus the second trimester, and 
second trimester versus the third trimester. The p values 
showed statistical significant difference in each of the 
three groups (p<0.001, p<0.001 and p<0.01 
respectively)
Table 3 shows the intra-group comparison of means of 
Cfactor VIII  value for control versus the study subjects 
in the first trimester, first versus second trimester, and 
second trimester versus third trimester. The p values 
showed statistical significant difference in each of the 
three groups (p <0.001 in all the group comparison). 
 
Table 3:
 Intra-group Comparison of Mean Factor VIII  Between  C
 
Control and Study Subjects in the First Trimester, First 
vs Second Trimester, Second vs Third Trimester.      

















































S = Statistical significance
 
Table 1:
-Mean Values of PT, PTT  & Fibrinogen FVIII 
C




 (Secs.)  
PTTk  
 (Secs.)  
Fibrinogen  
 (g/dl)  
Factor VIIIC
 (%)  
First  11  35  5.03ÿ3.4  111ÿ1.8
Second  10  33  5.67ÿ5.4  151ÿ2.1
Third  10  32  5.96ÿ6.0  119ÿ0.7






Intra-group Comparison of  Mean Fibrinogen Between 
First vs. Second Trimester, Second vs. Third Trimester
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k
Control and the Study Subjects in the First Trimester, 
Discussion 
Pregnancy has been identified as a hypercoagulable 
state. The levels of markers of haemostatic activation 
such as fibrinopeptide A and B (prothrombin fragment 
1+2), TAT (thrombin antithrombin complex) and D-
dimer similar to or higher than those found in patients 
following thrombo-embolic event, have been observed 
14.
in pregnancy  Incidence of pregnancy associated VTE 
is estimated to be 1/1000 deliveries, 5.5-6 times higher 
15
than in the female population . The normal 
haemostat ic  balance between coagulat ion 
factors/coagulation inhibitors, fibrinolytic factors and 
fibrinolytic inhibitors in pregnancy is tilted towards a 
hypercoagulable state, which is counterbalanced by 
14, 16
increased fibrinolytic activity  and decrease in factor 
17,18
XI and monocytes tissue factor expression . 
Substantial changes in procoagulant haemostatic 
changes in preparation for the haemostatic challenge of 
pregnancy is followed by increase in FXIII and FII in 
(19,20)early pregnancy  although there is a return to non-
pregnant level by the third trimester. On the other hand, 
there is a consistent increase through out pregnancy of 
10,13
factors XII, X, IX, VIII, VII, vWF, Fibrinogen . 
However, relatively low incidence of VTE occur 
because of the increase in fibrinolytic activity, brought 
about by increases in endothelial derived PAI-1 during 
the later stages of pregnancy and placental derived PAI-
 19,
2 which increases gradually from early pregnancy  In 
this study, prothrombin time and partial thromboplatin 
time with kaolin were shorter than the control values, 
thereby suggesting a hypercoagulable state. The mean 
prothrombin time of the pregnant women was 
significantly shorter than that of the control subjects (p 
< 0.001) Similarly the mean value of the Partial 
thromboplatin time with kaolin in pregnant women was 
significantly shorter than that of the control subjects  (p 
< 0.001).
The results of fibrinogen concentration of the pregnant 
women studied revealed a significant increase in 
fibrinogen level compared to controls. The mean 
fibrinogen level of the control subjects was 4.18g/dl 
(the range was between 3.7g/dl  4.5g/dl). These values 
are higher than the mean fibrinogen level of 2.50g/dl in 
Caucasians with a range of 1.5  4.0g/dl. The high level 
of fibrinogen in blacks has been attributed to endemic 
infections and parasite infestations.
The mean fibrinogen level steadily rose from 5.03g/dl 
in the first trimester, to 5.68g/dl in the second trimester 
and finally to 5.96g/dl in the third trimester.. This is in 
(21), (22)
agreement with other studies  that showed that 
fibrinogen level were always on the increase as the 
23pregnancy advances. Also, Kobayashi et al  found that 
fibrinogen was an extremely important factor in 
maintenance of pregnancy and that pregnancy is 
associated with increased level of fibrinogen, 
proportional to the gestational age. Also, there was a 
significant correlation of fibrinogen level with 
gestational age in both the study subjects. The increase 
C (24)in factor VIII  level is in agreement with Caires et al , 
who also found progressive increase in the level of 
C
Factor VIII  with gestational age. 
25Walker et al  observed that there was an increase in 
Cfactor VIII  level reaching its peak during the third 
trimester. The present work is in agreement in that from 
st
the 1  trimester there was an increase in value from 
111% to 151% in the second trimester but with a drop 
to 119% in the third trimester. This findings of an 
C
increase in factor VIII  levels in pregnancy in Nigerian 
patients is in keeping with the previous study of Noe, 
(26), C
D.A 1996  showed elevated factor VIII  in pregnant 
women.
The progressive hypercoagulability demonstrated in 
pregnancy is nature's way of preventing excessive 
bleeding during parturition. This is of tremendous 
advantage in individuals with inherited factor 
deficiency like von Willebrands disease (vWD), which 
tend to improve in pregnancy. vWD is an inherited ( 
usually autosomal dominant) bleeding disorder; 
c h a r a c t e r i z e d  b y  r e d u c e d  p l a t e l e t  
adhesiveness(usually <20% of normal) as a result of 
quantitative or qualitative defect in the multimeric 
molecular complex of the glycoprotein subunit (vWF 
multimers), leading commonly to muco-cutaneous  
27bleeding in spite of normal platelet count
The corollary of the above findings is that increased 
level of a coagulation factor in pregnancy is not an 
isolated phenomenon, and that the hypercoagulable 
state involves a complex mechanism so as to ensure 
that pregnant women do not bleed to death during 
childbirth.
During pregnancy and the immediate post partum 
period, the hypercoagulability could predispose to 
thrombosis, particularly where there are compounding 
predisposing factors to deep vein thrombosis (DVT) 
such as diabetes, prolonged immobilization, pelvic 
surgery, shock and haemoglobinopathies.
This study is of relevance in clinical practice in that 
significantly prolonged PTT   in conjunction with k
prolonged thrombin time and reduced platelet count; 
together with hypofibrinogenaemia (which becomes 
manifest when LDH is greater 240U/ml) in the pre-
eclamptic patient; have predictive value in detecting 
28,29
disseminated intravascular coagulopathy (DIC) . . 
The presence of DIC has a positive correlation with 
increasing severity of Pregnancy Induced 
28,29
Hypertension. . In  Hadatidiform mole, coagulation 
profile assessment is necessary to exclude the 
development of coagulopathy.
Coagulation Profiles in Pregnancy
5
In conclusion, this study showed ample evidence of a 
progressive hypercoagulable state with advancing 
pregnancy evidenced by shortened PT, PTT , k
Cprogressive increase factor VIII  and fibrinogen levels 
compared with the corresponding  values in the 
control subjects. Serial coagulation study is therefore 
suggested for all pregnant women, particularly in 
pregnant women with a previous or family history of 
venous thromboembolic disorders (VTE). Where 
global tests of coagulation and specific factors assay 
suggest moderately severe hypercoagulable state, 
prophylactic anticoagulation should be considered, 
particularly where there is additional predisposing 
factor to DVT such as pelvic surgery, shock, or 
prolonged immobilization. Patients with severe pre-
eclampsia and hydatidiform mole may develop 
coagulopathy and coagulation profile has predictive 
value in detecting DIC.
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